Tag: MENA

Combination Creates New Global Leader for ‘Near Me’ Customer Experience Solutions.

LOS ANGELES and BERLIN, June 15, 2021 (GLOBE NEWSWIRE) — Uberall, a global leader in ‘Near Me’ Marketing SaaS solutions announced today it received a capital investment of $115 million led by Bregal Milestone, Level Equity, United Internet and Uberall management, which will be deployed to accelerate growth in the U.S. and Canada.

As part of its growth strategy Uberall is simultaneously announcing it has signed a definitive agreement to acquire MomentFeed, the leading provider of Proximity Search Optimization in North America. Together Uberall and MomentFeed create a new, more powerful ‘Near Me’ Customer Experience platform with unsurpassed capabilities and global reach. The combined company will manage the online presence of 1.35 million business locations, more than any other current competitor. MomentFeed and Uberall count many of the world’s largest and most recognizable multi-location brands as their customers, including BP, KFC, Marks and Spencer, McDonald’s and Pizza Hut.

“As consumers re-emerge from a year or more of lockdowns, businesses are rebounding, and they must be able to match growing consumer demands to receive the in-store experiences and services they expect,” said Florian Hübner, co-founder and CEO of Uberall. “The combination of Uberall and MomentFeed helps us become the clear category leader with more innovative products, a world-class team, and the financial resources to fully deliver on the opportunity.”

Uberall and MomentFeed are long-time business partners with a similar vision and complementary product suite. The combined platform will bring together Uberall’s market-leading listings and reputation management products, as well as first-to-market features like Google local ads, and combine them with MomentFeed’s best-in-class local social capabilities, customer sentiment analysis and enterprise-grade service offering.

“As we saw the market trending towards consolidation, we considered several potential companies to merge with. Uberall was by far our most preferred,” said MomentFeed CEO Nick Hedges. “This combination makes enormous strategic sense for our customers, who represent the who’s-who of leading U.S. omni channel brands. It helps accelerate our already rapid pace of innovation, giving customers an even greater edge in the hyper-competitive world of ’Near Me’ Marketing.”

MomentFeed CEO Nick Hedges will join Uberall’s executive leadership team as Chief Strategy Officer and Executive Vice President North America, leading Uberall’s North American business unit which will have a significant sales, service and engineering footprint in California.

“We are thrilled to partner with the Uberall team for this next phase of growth. Our strategic investment will significantly accelerate Uberall’s ambition to become the leading ‘Near Me’ Customer Experience platform worldwide. Uberall’s differentiated full-suite solution is unsurpassed by competition in terms of integration and functionality, providing customers with a real edge to reach, interact with, and convert online customers. We look forward to supporting Florian, Nick and their talented team to deliver on their exciting innovation and expansion roadmap.” said Cyrus Shey, Managing Partner of Bregal Milestone.

About Uberall

Uberall empowers the world’s biggest brands to deliver a memorable ‘Near Me’ Customer Experience — from online interactions to offline sales.

As today’s consumers expect an omnichannel experience, they do not distinguish between online and offline anymore. Thus, the ‘Near Me’ customer journey consists of all the touchpoints that a consumer has with the local outlets of a brand: from finding, persuading, buying and recommending, to returning as a regular customer. Uberall’s platform enables businesses to bridge the gap between these touchpoints and facilitates a seamless customer experience that evokes positive emotions and customer satisfaction.

Uberall, founded in 2013 and headquartered in Berlin, Germany, has offices in 6 countries with close to 300 employees. Uberall currently services over 1,600 multi-location customers across 170 countries.

For further information visit www.uberall.com | LinkedIn | YouTube | Facebook | Twitter

About MomentFeed

MomentFeed is the leading Proximity Search Optimization platform trusted by many of the largest multi-location brands in the restaurant, retail, automotive, hospitality, and financial services industries. Proximity Search Optimization is gaining significant interest from CMOs of multi-location, national brands and franchises as a way to show up locally, at the precise moment a customer has a need. MomentFeed makes it possible for national brands to execute hyperlocal marketing campaigns at scale – driving local awareness, in-store traffic, and more calls for appointments and orders.

Founded in 2010, MomentFeed is headquartered in Santa Monica, California. An Inc 5000 Fastest Growing Privately Held Company, it was also named a Comparably Best Company.

For more information visit www.momentfeed.com | Twitter | LinkedIn | Facebook

Contact:
Adam Brett
516.320.0164
adam@crenshawcomm.com

LeddarTech joins Tech.AD Europe as the Lead Sponsor and as both a presenter and exhibitor at this live event at the Titanic Chaussee Berlin, Germany, on July 1-2, 2021. Join LeddarTech either in person or digitally by registering today at autonomous-driving-berlin.com.

QUEBEC CITY, June 15, 2021 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in Level 1-5 ADAS and AD sensing technology, is excited to be reigniting its physical event calendar as a lead sponsor and keynote speaker of Tech.AD. Tech.AD has long been recognized as one of Europe’s leading technical ADAS and AD conferences. LeddarTech’s CTO Pierre Olivier will serve on the honorary jury for the 8^th Annual Tech.AD Europe Awards. These awards honor individuals and organizations who have designed exceptional solutions or products that contribute to ADAS/AD automotive development.

With a focus on environmental sensing that reimagines ADAS and AD solutions, the LeddarTech team will be participating in several capacities at this event.

Keynote presentation: July 1, 2021, 4:45 p.m. – 5:05 p.m. CET

Topic: Sensing Modalities, Sensor Fusion, and Perception for Autonomous Driving. The speaker, Pierre Olivier, Chief Technology Officer of LeddarTech, will explore the challenges and exciting opportunities facing the ADAS and AD business community.

World Café session: July 2, 2021, 1:15 p.m. – 3:35 p.m. CET

Topic: Sensor Café – Object Fusion vs. Raw Sensor Fusion – What Is the Superior Solution? Moderators: Reza Rashidi Far, PhD, and André Malz, PhD, of LeddarTech’s Strategic Product Management division.

Exhibition booth (6): July 1-2, 2021.

LeddarTech will feature solutions that solve critical sensing and perception challenges across the automotive and mobility value chain. LeddarTech will present these solutions through an innovative approach of on-site and live-streaming demonstrations of:

• Mobility and ITS sensors, including the recently released Leddar™ Sight LiDAR and the award-winning Leddar™ Pixell;
• LeddarVision™, a sensor-fusion and perception solution that delivers highly accurate 3D environmental models for L1-5 autonomy;
• Special Feature: the Westfield AutoSweep, the UK’s first fully autonomous pure electric road sweeper, featuring the Leddar Pixell.

“Our technical teams from Israel, Germany, and Italy are excited to be joining our esteemed colleagues, peers, and partners at Tech.AD. Our much-anticipated return to in-person events is especially significant as we will be showcasing our customer Westfield’s autonomous AutoSweep POD, which features the Leddar Pixell,” stated Daniel Aitken, Vice-President, Global Marketing, Communications, and Product Management at LeddarTech. “Tech.AD provides an excellent opportunity to engage with many leaders in the industry both virtually and in person, and we look forward to demonstrating our latest technology, sharing our vision, and engaging with our customers,” Mr. Aitken continued. “Tech.AD is making all efforts to implement precautions to ensure a safe and fulfilling event for all delegates, and I welcome you to visit us in person or online during the event in July,” concluded Mr. Aitken.

For more information about Tech.AD, visit autonomous-driving-berlin.com.

Prior to Tech.AD register for the Automotive IQ Webinar: June 29, 2021, 11:00 a.m. – 12:00 p.m. ET

Topic: A Clean Sweep: How Adopting Autonomous Vehicle and EV Technology Is Paving the Way to Increased Road Sweeper Efficiency and Safety While Reducing Environmental Impact. Join Pierre Olivier, CTO of LeddarTech and Julian Turner, CEO of Westfield Technology Group, for this Automotive IQ hosted event.

Register here.

About LeddarTech

LeddarTech is a leader in environmental sensing platforms for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end-to-end environmental sensing company by enabling customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility market segments. With its LeddarVision™ sensor-fusion and perception platform and its cost-effective, scalable, and versatile LiDAR development solution for automotive-grade solid-state LiDARs based on the LeddarEngine™, LeddarTech enables Tier 1-2 automotive system integrators to develop full-stack sensing solutions for autonomy level 1 to 5. These solutions are actively deployed in autonomous shuttles, trucks, buses, delivery vehicles, smart cities/factories, and robotaxi applications. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 95 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook, and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications, and Product Management, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232
daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/2f336faf-ccca-4167-939e-c1dfcfc4c897

https://www.globenewswire.com/NewsRoom/AttachmentNg/84aebadf-f893-466e-8144-9b31e4d79c26

Mont-Saint-Guibert, Belgium – June 10, 2021, 11:45pm CET / 5:45pm ET – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced its unaudited, interim financial statements for the three months ended March 31, 2021.  In addition, Mr. Janke Dittmer has informed the Company that he will resign from his position as director immediately prior to and contingent upon the completion of an initial public offering in the United States.

First Quarter 2021 Results

	For the three month period ended March 31
(in thousands of EUR)	2021	2020
Revenue	185	—
Cost of goods sold	(52)	—
Gross Profit	133	—
General and administrative expenses	(1,818)	(1,178)
Research and development expenses	(852)	(7)
Clinical expenses	(342)	(177)
Manufacturing expenses	(901)	(62)
Quality assurance and regulatory expenses	(325)	(25)
Patents Fees & Related	(674)	(58)
Therapy Development expenses	(548)	(352)
Other operating income/(expenses)	4	(191)
Operating loss for the period	(5,323)	(2,050)
Financial income	4	19
Financial expense	(325)	(336)
Loss for the period before taxes	(5,644)	(2,367)
Income Taxes	(25)	(13)
Loss for the period	(5,669)	(2,380)
Other comprehensive loss
Items that may be subsequently reclassified to profit or loss (net of tax)
Currency translation differences	(70)	272
Total comprehensive loss for the year, net of tax	(5,739)	(2,108)
Loss attributable to equity holders	(5,739)	(2,108)

Revenue

Revenue was €185,000 for the three months ended March 31, 2021, compared to no revenue for the three months ended March 31, 2020. The increase in revenue was attributable to the Company’s commercialization of the Genio® system in Europe, which began in July 2020.

Cost of Goods Sold

Cost of goods sold was €52,000 for the three months ended March 31, 2021, compared to no cost for the three months ended March 31, 2020. The increase in cost of goods sold was attributable to the sales of the Genio® system in Europe, which began in July 2020.

General and Administrative Expenses. General and administrative expenses increased by €0.6 million, or 54%, from €1.2 million for the three months ended March 31, 2020 to €1.8 million for the three-months ended March 31, 2021 mainly due to an increase in consulting expenses. The increase in consulting and contractors’ fees includes variable compensations for an amount of €253,000 for the three months ended March 31, 2020 and €498,000 for the three-months ended March 31, 2021 related to a cash-settled share based payment transaction.

Research and Development Expenses. Before capitalization of €311,000 for the three months ended March 31, 2020, research and development expenses increased by €0.5 million, or 168%, from €318,000 (or €7,000 after capitalization of €311,000) for the three months ended March 31, 2020 to €0.9 million for the three months ended March 31, 2021, due to an increase in staff and consulting costs to support the Company’s R&D activities.

Clinical Expenses. Before capitalization of €1.4 million for the three months ended March 31, 2021 and capitalization of €568,000 for the three months ended March 31, 2020, clinical expenses increased by €1.1 million, or 139%, from €0.7 million (or €177,000 after capitalization of €568,000) for the three months ended March 31, 2020 to €1.8 million for the three months ended March 31, 2021 (or €342,000 after capitalization of €1.4 million). The increase in the expenses was mainly due to an increase in staff and consulting to support the completion of the BETTER SLEEP trial implantations, continuous recruitment for the EliSA trial and the ongoing DREAM IDE trial in the United States.

Manufacturing Expenses. Before capitalization of €215,000 for the three months ended March 31, 2021 and €578,000 for the three months ended March 31, 2020, manufacturing expenses increased by €0.5 million, or 74%, from €0.6 million (or €62,000 after capitalization of €578,000) for the three months ended March 31, 2020 to €1.1 million (or €901,000 after capitalization of €215,000) for the three months ended March 31, 2021. The increase was mainly due to an increase in staff, in the production and engineering team to support capacity and yield improvement, and in purchasing raw materials to support an increase in production.

Quality Assurance and Regulatory Expenses. Before capitalization of €133,000 for the three months ended March 31, 2021 and €263,000 for the three months ended March 31, 2020, quality assurance and regulatory expenses increased by €170,000, or 59%, from €288,000 (or €25,000 after capitalization of €263,000) for the three months ended March 31, 2020 to €458,000 (or €325,000 after capitalization of €133,000) for the three months ended March 31, 2021. The increase was mainly due to an increase in staff and QA & regulatory activities to support the manufacturing scaling-up process.

Patent Fees & Related Expenses. Before capitalization of €56,000 for the three months ended March 31, 2020, patent fees & related expenses increased by €560,000, or 491%, from €114,000 (or €58,000 after capitalization of €56,000) for the three months ended March 31, 2020 to €0.7 million for the three months ended March 31, 2021 due to expenses related to the in-licensing agreement with Vanderbilt University.

Therapy Development Expenses. Therapy Development expenses increased by €196,000, or 56%, from €352,000 for the three months ended March 31, 2020 to €0.5 million for the three months ended March 31, 2021. The increase in the expenses was mainly due to an increase in staff and consulting to support the launch the commercialization of the Genio® system in Europe.

Other Operating Income / (Expenses). The Company had other operating expenses of €191,000 for the three months ended March 31, 2020 and operating income of €4,000 for the three months ended March 31, 2021. The increase in expenses was mainly due to the impact of the initial measurement and re-measurement of the financial debt.

Operating Loss

The increase of operating loss from €2.1 million for the three months ended March 31, 2020 to €5.7 million for the three months ended March 31, 2021, or a change of €3.3 million, was due to increases of activities in all departments. The Company currently conducting three clinical trials to continue gathering clinical data and obtain regulatory approvals. In June 2020, the Company obtained IDE approval to start the DREAM trial in the United States. In line with this strategy, the Company continues to invest in research and development to improve and develop the next generation of the Genio® system and prepare for scaling-up of production capacities.

Cash Position

Cash and cash equivalents totaled €86.2 million on March 31, 2021, as compared to €92.3 million on December 31, 2020.

Net cash used in operations was €4.2 million for the three months ended March 31, 2021 compared to €1.2 million for the three months ended March 31, 2020. The increase of €3.0 million was primarily due to an increase in a loss for the period of €3.3 million that was mainly attributable to increased general and administrative expenses, research and development expenses, manufacturing expenses and therapy development expenses, which were offset by a positive variation in the working capital of €0.5 million.

Net cash used in investing activities for each of the three months ended March 31, 2021 and the three months ended March 31, 2020 was €1.8 million.

Net cash used in financing activities for the three months ended March 31, 2021 was €104,000 compared to €24.8 million of net cash provided by financing activities during the three months ended March 31, 2020. The decrease was due to a lack of capital increase during the first quarter of 2021.

Outlook for 2021

The Company’s business, operational, and clinical outlook for 2021 include the following expected milestones and goals:

• Ramp up EU revenue and build a dedicated sales team in Germany
• Open second independent manufacturing site in Belgium, in addition to existing site in Israel
• Complete DREAM pivotal trial enrollment

First quarter report 2021
Nyxoah’s financial report for the three months ended March 31, 2021, including details of the unaudited consolidated results, are available on the investor page of Nyxoah’s website (https://investors.nyxoah.com/financials).

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a CE-validated, patient-centered, next generation hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Following the successful completion of the BLAST OSA study in patients with moderate to severe OSA, the Genio® system received its European CE Mark in 2019. The Company is currently conducting the BETTER SLEEP study in Australia and New Zealand for therapy indication expansion, the DREAM IDE pivotal study for FDA approval and a post-marketing EliSA study in Europe to confirm the long-term safety and efficacy of the Genio® system.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal
law to investigational use in the United States.

Forward-looking statements
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

For further information, please contact:
Nyxoah
Fabian Suarez, Chief Financial Officer
fabian.suarez@nyxoah.com
+32 10 22 24 55

Gilmartin Group
Vivian Cervantes

vivian.cervantes@gilmartinir.com

Attachment

• ENGLISH – Q1 Results PR

Nyxoah files Registration Statement for Proposed Initial Public Offering in the United States

Mont-Saint-Guibert, Belgium – June 10, 2021, 11:30pm CET / 5:30pm ET – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of its ordinary shares, which are expected to be listed on the NASDAQ Global Market in the United States.  The number of ordinary shares to be offered and the price for the proposed offering have not yet been determined.

Nyxoah’s ordinary shares are currently listed on Euronext Brussels under the symbol “NYXH”. An application has been made to list the ordinary shares on the NASDAQ Global Market under the same symbol.

Piper Sandler, Stifel and Cantor are acting as joint book-running managers for the proposed offering. Degroof Petercam is acting as a manager.

A registration statement on Form F-1 has been filed with the SEC but has not yet become effective. The ordinary shares may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification or publication of an offering prospectus under the securities laws of any such state or jurisdiction.

The proposed offering of ordinary shares in the United States will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the proposed offering can be obtained from Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by e-mail at prospectus@psc.com, or by phone at (800) 747-3924; Stifel, Nicolaus & Company, Incorporated at Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 364-2720, or by email at syndprospectus@stifel.com; or Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Avenue, 4th Floor, New York, New York 10022; email: prospectus@cantor.com.

Contacts:

Nyxoah
Fabian Suarez, Chief Financial Officer
fabian.suarez@nyxoah.com
+32 10 22 24 55

Gilmartin Group
Vivian Cervantes
vivian.cervantes@gilmartinir.com

Attachment

• ENGLISH – Nyxoah Public Flip Press Release

Combining Layout International’s NewsPublish and Sophi.io’s smart AI and ML engine reduces the hours long process of print laydown to just minutes

TORONTO, June 10, 2021 (GLOBE NEWSWIRE) — Sophi.io, a suite of AI-powered optimization, prediction and automation tools developed by The Globe and Mail, has partnered with Layout International, a supplier of cutting-edge enterprise technology, to transform print production. Sophi will provide the smart AI/ML technology to fully automate the end-to-end print production workflow to save publishers time and money and enable them to focus on creating high quality content.

Print laydown is typically a long and arduous process, involving multiple editors and page designers and taking hours to complete. Without the rigid constraints of a template, Layout International customers will now have the opportunity to create a print-ready paper that is indecipherable from a paper prepared by human page designers, and the entire process takes just minutes. And for Layout International’s over 200 customers, this partnership means seamless integration of Sophi into their current NewsPublish editorial workflow.

“We’re excited that working with Sophi.io enables us to offer our customers cutting edge new capabilities in the form of an end-to-end automated print solution that dramatically increases efficiencies. Our customers will be able to run and rerun their print paper in just minutes, whenever they chose, all within the NewsPublish Enterprise content management system that they already use daily,” said Jean-Michel Habis, CEO of Layout International.

The Sophi suite of tools is designed to identify an organization’s most valuable content (not the most popular content, but the content that drives conversions or retention or the metric that matters most to that organization) and place it in the most valuable places across their digital entities, or behind a paywall when the subscription revenue outweighs the predicted advertising revenue. In addition to NewsPublish powered by Sophi.io, Sophi provides site automation, a fully dynamic, real-time, personalized paywall, and analytics solutions to publishers across the world.

“Print laydown is a massive undertaking,” said Greg Doufas, Chief Technology Officer at The Globe and Mail. “We see this partnership with Layout International giving publishers the freedom to focus on content creation and the specific design elements that page designers want to spend their energy on. The best part is that NewsPublish powered by Sophi.io is getting better and smarter every day, so Layout International customers will always be on the cutting edge of technology with this solution.”

To learn more, please visit www.newspublish.org or email sales@layoutintl.com.

About Layout International
Layout International (www.layoutintl.com) meets the growing technological needs in the market by providing highly customizable enterprise solutions. They serve more than 200 clients, supplying them with cutting-edge technology to improve the way they work. They enable many organizations to digitally transform their processes, migrate and integrate to work on a single platform.

Layout International Media Contact
Ghassan Halawi
Vice President of Sales, Layout International
+961 70 855685
ghalawi@layoutintl.com

About Sophi.io
Sophi.io (https://www.sophi.io) is a suite of AI-powered optimization and prediction tools that helps content publishers make important strategic and tactical decisions. Sophi solutions range from Sophi Site Automation and Sophi for Paywalls to Sophi Analytics, a decision-support system for content publishers. Sophi is designed to improve the metrics that matter most to your business, such as subscriber retention and acquisition, engagement, recency, frequency and volume.

Sophi.io Media Contact
Jamie Rubenovitch
Head of Marketing, Sophi.io
The Globe and Mail
416-585-3355
jrubenovitch@globeandmail.com

Zoom Phone Appliances Provide an All-In-One Desk Phone Solution for Calls and Meetings, with Hardware Solutions from Poly and Yealink

SAN JOSE, Calif., June 09, 2021 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today announced the launch of Zoom Phone Appliances, a new category of hardware optimized for the hybrid workforce, from home offices to shared huddle spaces, addressing use cases across industries. Zoom Phone Appliances combine Zoom technology with hardware from Poly and Yealink to provide video and audio capabilities and touch display, in an all-in-one desk phone solution for HD video meetings, phone calls, and interactive whiteboarding.

“Zoom continues to demonstrate fast pace of innovation and ability to scale globally with its robust cloud phone offering, Zoom Phone,” said Elka Popova, VP of Connected Work Research at Frost & Sullivan. “Zoom Phone has always been a disruptive alternative to legacy phone solutions and the new appliance program further enhances its value proposition by enabling businesses to video-enable workspaces with purpose-built appliances that are easy to procure, deploy, and manage.”

“The traditional workplace is evolving and adapting, and our goal is to empower the workforce to accomplish more by blurring the lines between voice and video,” said Graeme Geddes, Head of Zoom Phone and Zoom Rooms at Zoom. “The new Zoom Phone Appliance program boasts a selection of purpose-built Zoom Phone hardware from Poly and Yealink, streamlining communications, removing friction, and enabling a powerful communications experience.”

Zoom Phone Appliances simplify licensing, installation, use, and management, benefitting both the end users and IT departments. Additional highlights of Zoom Phone Appliances include:

• A full-featured desk phone with powerful Zoom capabilities. Zoom Phone Appliances are always on, and always ready for instant communication and collaboration. Easily start ad-hoc or scheduled meetings, make and receive phone calls, check voicemail, and virtually collaborate with content sharing and annotation
• Centralized management through Zoom Admin Portal: Simplified, scalable, centralized management with remote provisioning and updates
• No additional licensing required: Login to a Zoom Phone Appliance with your Zoom account and create an instant office experience
• Personalized for the user: Syncs with the user calendar, status, meeting settings, and phone for an integrated video-first unified communications experience
• Simplified onboarding with Zero-touch provisioning: Minimizes need for IT support with a simplified set-up and user experience
• Touch display with interactive whiteboarding: Collaborate with colleagues with interactive whiteboarding that can easily be exported and shared
• Zoom Certified: Zoom Phone Appliances are introducing a new certified hardware category, ensuring these devices are purpose-built for an optimal Zoom Phone and meetings experience. More devices will be added to this category over time

The inaugural class of Zoom Phone Appliances features innovative solutions from two Zoom hardware partners — Poly and Yealink — with others to follow.

Poly CCX 600 Desk Phone and CCX 700 Desk Phone with integrated video camera

“We are excited to be among the first to integrate a native Zoom experience into our Poly CCX family, as Zoom Phone Appliances,” said John Lamarque, Vice President and General Manager, Voice Collaboration, Poly. “This brings the Zoom platform that we all know and love front and center on the device’s touch display, providing a powerful and immersive experience.”

Yealink VP59 Smart Video Phone

“We are delighted to unveil the new, reliable, and cutting-edge VP59 video phone, a Zoom Phone Appliance,” said Alvin Liao, Vice President of Product, at Yealink. “The VP59 video phone’s touch display will be powered by Zoom’s industry-leading video communications platform, providing customers with a user-friendly interface and intuitive experience.”

Zoom Phone Appliances are available through the Zoom Hardware-as-a-Service program as well as from authorized Poly and Yealink resellers. To learn more about Zoom Phone Appliances, visit the Zoom Phone Appliances website and read our blog.

About Zoom
Zoom is for you. We help you express ideas, connect to others, and build toward a future limited only by your imagination. Our frictionless communications platform is the only one that started with video as its foundation, and we have set the standard for innovation ever since. That is why we are an intuitive, scalable, and secure choice for individuals, small businesses, and large enterprises alike. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Visit zoom.com and follow @zoom.

Zoom Public Relations
Farshad Hashmatulla
Product PR Manager
press@zoom.us